Delivery Order SPE2DB22D1106-SPE2DB25FEZZ6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,714.16 to AmerisourceBergen Drug Corp for Wellbutrin XL 150 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The place of...
- This federal contract award is a delivery order with a firm fixed price valued at $1,471.86, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wellbutrin XL 300 mg tablets, with a performance period extending through June 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Wellbutrin XL 150 mg tablets. The $4,262.28 fixed-price contract has a performance period through July 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to supply a broad range of pharmaceutical products and medical supplies to...
- This federal contract award is for the delivery of Wellbutrin XL 150 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,280.68 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of September 25, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit organization and subsidiary of AmerisourceBergen Corporation. The contract is for the supply of Wellbutrin XL 150 mg tablets, with a ceiling value of $1,756.27 and a period of performance through April 1, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This federal contract award is for the delivery of Wellbutrin XL 150 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $25,610.70, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price pricing type and a completion date of January 16, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,433.58, is for the delivery of Wellbutrin XL 150 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 13, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
- This is a $3,724.90 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for Wellbutrin SR 200 mg tablets, a prescription medication, and has a firm fixed price. It is not a set-aside contract. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- This federal contract award, with the ID SPE2DB22D1017|SPE2DB24FF3BN, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the supply of WELLBUTRIN XL 300 MG TABLET 30S, with a ceiling value of $11,067.76 and a completion date of February 21, 2024. The contract is not designated as a set-aside and appears to be part...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Wellbutrin 300mg medication. The contract has a firm fixed price of $1,239.12 and a period of performance through May 22, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZZ6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,032.65 to AmerisourceBergen Drug Corp for the supply of Wellbutrin XL 300 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreement with the DLA. This delivery order falls under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems with a comprehensive range of pharmaceutical products and medical supplies. The company's established presence as a pharmaceutical prime vendor demonstrates its capability to fulfill federal medical supply requirements efficiently across multiple therapeutic domains in support of military and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/28/25 |